Skip to content

Clinical trials

Phase 2 Multiple Myeloma trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 2 Country / region: Poland Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20081
20092
20122
20141
20164
20183
20191
20212
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated3
Unknown status3
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC5
Bristol-Myers Squibb2
Janssen-Cilag International NV2
Takeda2
Amgen1
Eli Lilly and Company1
Erasme University Hospital1
GlaxoSmithKline1
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice1
Millennium Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma21
Recurrence3
Lymphoma2
Neoplasms2
Neoplasms, Plasma Cell2
Amyloidosis1
Bone Marrow Neoplasms1
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Colonic Neoplasms1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.